US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist
  • 12.2207
  • -0.0493-0.40%
Trading Mar 11 09:58 ET
286.59MMarket Cap-19.71P/E (TTM)

Benitec Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
2.74%75K
7K
12.50%54K
Operating revenue
--0
--0
--0
--0
--0
--0
--0
2.74%75K
--7K
12.50%54K
Cost of revenue
1K
Gross profit
-107.14%-1K
Operating expense
24.31%8.61M
-1.41%5.79M
17.40%22.49M
21.75%5.55M
-5.78%4.14M
23.15%6.93M
28.25%5.87M
6.91%19.16M
-3.64%4.56M
25.29%4.4M
Selling and administrative expenses
93.97%3.54M
42.23%2.21M
9.51%6.99M
48.50%2.04M
28.50%1.58M
-2.09%1.82M
-19.22%1.55M
-3.97%6.38M
-11.72%1.37M
-8.15%1.23M
-General and administrative expense
93.97%3.54M
42.23%2.21M
9.51%6.99M
48.50%2.04M
28.50%1.58M
-2.09%1.82M
-19.22%1.55M
-3.97%6.38M
-11.72%1.37M
-8.15%1.23M
Research and development costs
-0.59%5.07M
-19.06%3.59M
22.19%15.61M
10.23%3.51M
-18.98%2.57M
35.66%5.1M
66.50%4.43M
13.33%12.77M
0.31%3.19M
45.88%3.17M
Other operating expenses
----
----
---108K
--0
---3K
----
---106K
----
----
----
Operating profit
-24.30%-8.61M
1.41%-5.79M
-17.87%-22.49M
-21.93%-5.55M
4.61%-4.14M
-23.48%-6.93M
-28.25%-5.87M
-6.87%-19.08M
3.97%-4.55M
-25.46%-4.34M
Net non-operating interest income expense
13,816.67%823K
10,166.67%604K
2,839.39%904K
11,600.00%920K
42.86%-4K
33.33%-6K
33.33%-6K
-3.13%-33K
20.00%-8K
30.00%-7K
Non-operating interest income
--823K
----
----
----
----
----
----
----
----
----
Non-operating interest expense
----
----
----
----
-42.86%4K
-33.33%6K
----
----
----
-30.00%7K
Total other finance cost
----
-10,166.67%-604K
-2,839.39%-904K
----
----
----
--6K
--33K
----
----
Other net income (expense)
218.52%430K
272.97%128K
63.17%-165K
10.68%-92K
-173.47%-134K
-35.10%135K
85.32%-74K
-39.13%-448K
67.71%-103K
-125.13%-49K
Gain on sale of security
-294.70%-294K
266.07%93K
109.33%39K
369.57%62K
-140.82%-118K
-4.43%151K
88.89%-56K
-72.02%-418K
91.45%-23K
-121.88%-49K
Special income (charges)
--764K
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
---764K
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-150.00%-40K
294.44%35K
-580.00%-204K
-92.50%-154K
---16K
-132.00%-16K
---18K
62.03%-30K
-60.00%-80K
----
Income before tax
-8.22%-7.36M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
Income tax
Net income
-8.22%-7.36M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
Net income continuous Operations
-8.22%-7.36M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
Minority interest income
Net income attributable to the parent company
-8.22%-7.36M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
Preferred stock dividends
Other preferred stock dividends
0
0
619K
0
619K
0
Net income attributable to common stockholders
-8.22%-7.36M
23.03%-5.06M
-14.35%-22.37M
-14.55%-5.34M
2.68%-4.28M
-25.63%-6.8M
-29.06%-6.57M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
Basic earnings per share
87.50%-0.33
84.26%-0.48
60.98%-5.51
80.02%-0.5293
38.58%-1.64
20.96%-2.64
61.78%-3.05
62.72%-14.12
74.79%-2.65
60.74%-2.67
Diluted earnings per share
87.50%-0.33
84.26%-0.48
60.98%-5.51
80.02%-0.5293
38.58%-1.64
20.96%-2.64
61.78%-3.05
62.72%-14.12
74.79%-2.65
60.74%-2.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023
Total revenue 00000002.74%75K7K12.50%54K
Operating revenue --0--0--0--0--0--0--02.74%75K--7K12.50%54K
Cost of revenue 1K
Gross profit -107.14%-1K
Operating expense 24.31%8.61M-1.41%5.79M17.40%22.49M21.75%5.55M-5.78%4.14M23.15%6.93M28.25%5.87M6.91%19.16M-3.64%4.56M25.29%4.4M
Selling and administrative expenses 93.97%3.54M42.23%2.21M9.51%6.99M48.50%2.04M28.50%1.58M-2.09%1.82M-19.22%1.55M-3.97%6.38M-11.72%1.37M-8.15%1.23M
-General and administrative expense 93.97%3.54M42.23%2.21M9.51%6.99M48.50%2.04M28.50%1.58M-2.09%1.82M-19.22%1.55M-3.97%6.38M-11.72%1.37M-8.15%1.23M
Research and development costs -0.59%5.07M-19.06%3.59M22.19%15.61M10.23%3.51M-18.98%2.57M35.66%5.1M66.50%4.43M13.33%12.77M0.31%3.19M45.88%3.17M
Other operating expenses -----------108K--0---3K-------106K------------
Operating profit -24.30%-8.61M1.41%-5.79M-17.87%-22.49M-21.93%-5.55M4.61%-4.14M-23.48%-6.93M-28.25%-5.87M-6.87%-19.08M3.97%-4.55M-25.46%-4.34M
Net non-operating interest income expense 13,816.67%823K10,166.67%604K2,839.39%904K11,600.00%920K42.86%-4K33.33%-6K33.33%-6K-3.13%-33K20.00%-8K30.00%-7K
Non-operating interest income --823K------------------------------------
Non-operating interest expense -----------------42.86%4K-33.33%6K-------------30.00%7K
Total other finance cost -----10,166.67%-604K-2,839.39%-904K--------------6K--33K--------
Other net income (expense) 218.52%430K272.97%128K63.17%-165K10.68%-92K-173.47%-134K-35.10%135K85.32%-74K-39.13%-448K67.71%-103K-125.13%-49K
Gain on sale of security -294.70%-294K266.07%93K109.33%39K369.57%62K-140.82%-118K-4.43%151K88.89%-56K-72.02%-418K91.45%-23K-121.88%-49K
Special income (charges) --764K------------------0----------------
-Less:Other special charges ---764K------------------------------------
Other non- operating income (expenses) -150.00%-40K294.44%35K-580.00%-204K-92.50%-154K---16K-132.00%-16K---18K62.03%-30K-60.00%-80K----
Income before tax -8.22%-7.36M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M
Income tax
Net income -8.22%-7.36M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M
Net income continuous Operations -8.22%-7.36M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M
Minority interest income
Net income attributable to the parent company -8.22%-7.36M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M
Preferred stock dividends
Other preferred stock dividends 00619K0619K0
Net income attributable to common stockholders -8.22%-7.36M23.03%-5.06M-14.35%-22.37M-14.55%-5.34M2.68%-4.28M-25.63%-6.8M-29.06%-6.57M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M
Basic earnings per share 87.50%-0.3384.26%-0.4860.98%-5.5180.02%-0.529338.58%-1.6420.96%-2.6461.78%-3.0562.72%-14.1274.79%-2.6560.74%-2.67
Diluted earnings per share 87.50%-0.3384.26%-0.4860.98%-5.5180.02%-0.529338.58%-1.6420.96%-2.6461.78%-3.0562.72%-14.1274.79%-2.6560.74%-2.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.